Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Myasthenia Gravis × Steroids × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 1 Neoplasm Metastasis 1 Myasthenia Gravis 1 Multiple Myeloma 1 Lymphoma, Follicular 1 Lymphoma 1 Hemangioma 1

Interventions

rozanolixizumab 4 eculizumab 4 zilucoplan 3 efgartigimod alfa 3 Rituximab 2 Prednisone 2 Amifampridine 2 thymoglobulin 1 satralizumab 1 rhoA GTP-Binding Protein 1 ravulizumab 1 inebilizumab 1 gamma-Globulins 1 Thymectomy 1 Sugars 1 Steroids 1 Sodium Chloride 1 Robotic Surgical Procedures 1 Prednisolone 1 Methylprednisolone 1 Methotrexate 1 Mesna 1 Hizentra 1 Hematopoietic Stem Cell Transplantation 1 Granulocyte Colony-Stimulating Factor 1 Fluid Therapy 1 Cyclophosphamide 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00995722 2017-06-02

EPITOME'

University of Miami

Phase 3 Terminated

11 enrolled 14 charts

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡